Scientific studies & consumer anecdotes about healthier living by reversing NAD+ decline (for information purposes only)

Month: September 2020

MD and Anti-Aging Expert: Taking NAD Boosters “Crucial”

Dr. Sandra Kaufmann is Chief of Pediatric Anesthesia at Children’s Hospital in Hollywood, FL. On the side, she founded an Anti-Aging Institute and is author of The Kaufmann Protocol: Why We Age and How to Stop It. She recently wrote a post on NAD — but left lots of questions on NAD boosters unanswered. Fortunately, thanks to her many podcast appearances we can piece together what she really thinks.

Nestlé Health Science Launches New Site with NAD a Major Focus

Earlier this month, Nestlé Health Science (a subsidiary of Nestlé) launched a new site to track the latest research on aging. One key site focus is the role NAD decline plays in the aging process. In the very short video embedded below, Nestle does a good job of explaining NAD:

PODCAST: Dr Hoffman Explains Why He Recommends Nicotinamide Riboside (NR) to Patients

Dr. Ronald Hoffman MD often talks about taking NAD boosters on his Intelligent Medicine radio show. A few days ago, he devoted a segment to new pre-clinical research on Nicotinamide Riboside “NR” (FAQs) (Reviews). Key quotes:

How Much Nicotinamide Riboside (NR) Should You Feed Your Pet?

We know that lots of people give their pets Nicotinamide Riboside (NR) (Reviews) hoping to improve their health. But how much should you give them? In response to this very question posted in the comments section at RaisingNAD, the Chromadex (Nicotinamide Riboside “NR” (FAQs)) Scientific & Regulatory Affairs team gave the following advice.

INTERVIEW: Is Nicotinamide Riboside (NR) Safe?

If the New England Patriots take Nicotinamide Riboside “NR” (FAQs) (Reviews), one would assume it’s safe. That said, in an interview this week with NUTRAIngredients USA, NAD expert Dr. Charles Brenner offered further evidence:

At Investor Conference, Chromadex Explains NAD

Small-cap public companies typically use investor conferences to pitch their stories in brief. Chromadex (Nicotinamide Riboside “NR” (FAQs) (Reviews)) did so at the LD Conference yesterday. One can assume they were targeting an audience of non-scientists. Here’s how they explained NAD:

Powered by WordPress & Theme by Anders Norén